All Articles

Suralink's new AI agents move beyond simple automation, tackling accounting's costly 'rework cycle' to boost efficiency and transform client collaboration.

A new report reveals Americans are sitting on $750 billion in gold jewelry. As AI platforms disrupt old appraisal models, it's time to rethink this hidden wealth.

Amid market volatility, Ability Insurance's new guaranteed annuities offer a safe haven, but how does their B+ rating stack up in a competitive field?

Haoxi Health announces a second reverse split in three months, a move to save its Nasdaq listing that investors see as a red flag, despite its strategic AI push.

While others chase fleeting trends, Cargojet's 24-year ISO 9001 certification reveals a deep moat of operational excellence. Here's the why.

With Coco Gauff and Taylor Fritz, ŌURA isn't just selling a smart ring. It's selling a new philosophy of athletic success built on data, recovery, and story.

A new technique bypasses the pitch, asking buyers to let their own AI deliver the verdict. It's a radical bet on product truth in the age of AI.

Alto's new Private Deal Room gives advisors a streamlined path to private deals, aiming to unlock a massive, untapped pool of retirement funds for clients.

A new alliance is betting big on resurrecting 3D TV by ditching the glasses. We analyze if their advanced tech can finally make immersive viewing a shared reality.

With its third Inc. 5000 win, Thoropass’s AI-native platform proves that automation is the future for navigating complex cybersecurity compliance.

As HSDT prepares to report Q2 results, investors are watching closely. Is its unique strategy of tying shareholder value directly to the Solana ecosystem paying off?

OneDigital's new AI platform promises to shift benefits from a cost-cutting exercise to a strategic investment. But does it work? A deep dive.

A boutique bank just handed over a 50% stake to two star tech bankers. It's more than a hire; it's a strategic reset signaling a new model for Wall Street.

With a cash runway into 2029, Avalyn Pharma is advancing a novel inhaled drug platform, hitting key clinical milestones to challenge an oral-dominated market.

Docufree's 743-spot leap on the Inc. 5000 list isn't just about growth. It's about a critical shift toward trusted, AI-ready data as the new foundation for enterprise AI.

On World Elephant Day, a campaign to free an elephant named Joyce from Six Flags ignites a fierce debate on ethics, activism, and corporate responsibility.

A major alliance of urban schools is reframing the lunch line as the front line of preventive healthcare, appointing a doctor to tackle childhood disease.

Clearwave's new 'agentic workforce' automates the entire patient journey. It promises massive efficiency gains, but what is the human cost and benefit?

A startup is emerging with a bold claim: it can make cloud seeding precise, verifiable, and accountable. But can technology truly tame our turbulent climate?

A shocking new report finds only 5% of employees use GenAI effectively. The key isn't the tool, but the human skill and governance behind it.